To help you understand Results Innovator better: Following is an alphabetical index of the companies results of which appear in this issue. The first two columns in the results tabulation show the sales and net profit of the previous accounting year. Results of the first, second, third and fourth quarters of the current year follow this. Below this, the ‘% change’ row indicates the per cent change compared to the corresponding period of the previous year. All figures are in crores.

Aarti Drugs Aarti Drugs (33)

Abbott Laboratories Abbott Laboratories (4)

Ajanta Pharma Ajanta Pharma (42)

American Remedies American Remedies (50)

Astra-IDL Astra IDL (48)

Aurobindo Pharma Aurobindo Pharma (29)

Bal Pharma Bal Pharma (19)

Cadila Healthcare Cadila Healthcare (45)

Cipla Cipla (12)

Dabur India Dabur India (23)

Dr. Reddy’s Dr. Reddy’s (21)

Duphar Interfran Duphar Interfran (34)

E. Merck E. Merck (44)

Elder Pharma Elder Pharma. (40)

FDC FDC (31)

Glaxo Glaxo (8)

Glenmark Glenmark (32)

Hoechst-Marion Roussel Hoechst-Marion Roussel (41)

Ind-Swift Laboratories Ind-Swift Laboratories (27)

Ipca Laboratories Ipca Laboratories (20)

J B Chemicals J B Chemicals (22)

Jenburkt Jenburkt (38)

Knoll Pharmaceuticals Knoll Pharmaceuticals (15)

Kopran Kopran (35)

Krebs Biochem Krebs Biochem (37)

Lupin Laboratories Lupin Laboratories (1)

Makers Laboratories Makers Laboratories (17)

Max India Max India (39)

Morepen Laboratories Morepen Laboratories (24)

Neuland Laboratories Neuland Laboratories (11)

Nicholas Piramal Nicholas Piramal (25)

Novartis India Novartis India (30)

Orchid Chemicals Orchid Chemicals (2)

Panacea Biotech Panacea Biotech (13)

Parke Davis Parke Davis (16)

Pfizer Pfizer (3)

Punjab Chemicals Punjab Chemicals (5)

Ranbaxy Laboratories Ranbaxy Laboratories (7)

Shashun Chemicals Shashun Chemicals (9)

Siris Siris (36)

SmithKline Beecham Pharma SmithKline Beecham Pharma. (43)

Sun Pharmaceuticals Sun Pharmaceuticals (18)

Suven Pharmaceuticals Suven Pharmaceuticals (10)

Torrent Pharmaceuticals Torrent Pharmaceuticals (14)

Unichem Laboratories Unichem Laboratories (6)

Veronica Laboratories Veronica Laboratories (28)

Vorin Laboratories Vorin Laboratories (46)

Wockhard Wockhardt (26)

Wyeth Lederle Wyeth Lederle (47)

Zydus Cadila Zydus Cadila (49)

PHARMACEUTICAL RESULTS INNOVATOR – THE BENCHMARKING TOOL

No.

Comp.

Acc. Year

Result

Quarter 1

Quarter 2

Quarter 3

Quarter 4

Result

(Cr.)

(Cr.)

(Cr.)

(Cr.)

(Cr.)

(Cr.)

(Cr.)

(Cr.)

(Cr.)

(Cr.)

(Cr.)

(Cr.)

1

Lupin Labs.

Mar.02

956.9

72

-

-

242.2

23.7

% chng.

-

+6

+20

-

-

na

na

2

Mar.01

359.5

38.59

-

90.2

8.1

-

-

-

92.5

8.17

% chng.

-

-

-

-

+6

+2

-

-

-

-3

-20

3

Pfizer

Nov.01

-

-

-

-

-

100.7

11.4

-

-

-

% chng.

-

-

-

-

-

-

+9

+7

-

-

-

4

Abbott Labs.

Mar.01

-

-

-

-

-

-

-

-

-

-

% chng.

-

-

-

-

-

-

-

-

-

-

-

5

Pun. Chem.

Mar.01

-

-

-

-

-

-

-

-

-

-

% chng.

-

-

-

-

-

-

-

-

-

-

-

6

Unichem Labs.

Mar.02

250.8

19.92

83.0

9.84

301

31

% chng.

-

+18

+38

+21

+55

7

Ranbaxy Labs.

Dec.00

552.9

94.9

% chng.

-

+24

+70

8

Glaxo

Dec.01

1097.4

43.98

-

-

-

-

-

-

-

-

% chng.

-

+17

-38

-

-

-

-

-

-

-

-

9

Chem.

Mar.01

175.7

20.46

-

37.53

1.06

-

-

-

42.44

3.38

% chng.

-

-

-

-

-22

-83

-

-

-

-2

-26

10

Suven Pharma.

Mar.02

48.71

17.51

-

-

-

-

-

-

10.16

2.79

% chng.

-

-

-

-

-

-

-

-

-

-18

-41

11

Neuland Labs.

Mar.01

-

-

-

-

-

-

-

-

-

-

% chng.

-

-

-

-

-

-

-

-

-

-

-

12

Cipla

Mar.02

1047

179

-

366.2

62.6

-

-

-

485.6

61.7

1386

229.2

% chng.

-

-

-

-

+32

+17

-

-

-

+48

+79

+32

+28

13

Mar.01

195.1

25.93

-

-

-

-

-

-

43.72

4.68

% chng.

-

-

-

-

-

-

-

-

-

+36

+27

14

Pharma.

Mar.01

-

-

-

-

-

-

-

-

-

-

442.2

49.9

% chng.

-

-

-

-

-

-

-

-

-

-

-

+9

+20

15

Dec.01

-

93.2

12.2

-

-

-

-

-

% chng.

-

-

+3.4

-48

-

-

-

-

-

16

Feb.02

211.6

62.45

-

-

52.11

10.71

57.09

5.16

% chng.

-

-

-

+4

+53

-2

+34

17

Mar.01

-

-

-

-

-

-

-

-

-

-

% chng.

-

-

-

-

-

-

-

-

-

-

-

18

Mar.02

747.8

172.3

180.3

40.3

196.1

48.1

% chng.

-

+22

+27

+10

+28

+29

+49

19

Mar.02

36.99

1.42

11.66

.57

-

-

11.39

.6

% chng.

-

+21

+50

-

-

+25

+300

20

Mar.01

372.3

26.12

-

98.6

2.1

-

-

-

110.8

8.7

% chng.

-

-

-

-

+2

-70

-

-

-

+13

+7

21

Dr. Reddy’s

Mar.02

984.1

144.4

400.6

161.5

-

-

494.3

143.4

% chng.

-

+70

+369

-

-

+200

+387

No.

Comp.

Acc. Year

Result

Quarter 1

Quarter 2

Quarter 3

Quarter 4

Result

(Cr.)

(Cr.)

(Cr.)

(Cr.)

(Cr.)

(Cr.)

(Cr.)

(Cr.)

(Cr.)

(Cr.)

(Cr.)

(Cr.)

22

J B Chem.

Mar.’02

237.5

31.23

78.36

14.12

-

-

55.1

6.99

% chng.

-

+20

+82

-

-

+23

+21

23

Mar.’02

1166

319

22.33

-

-

% chng.

-

+1

+1

-

-

24

Mar.’02

429.7

73.2

122

36.61

-

-

119.2

23.81

% chng.

-

+10

+53

-

-

+13

+15

25

Mar.’02

566.7

66.46

-

-

254.3

14.08

946.5

48.2

% chng.

-

-

-

+76

-23

-27

26

Dec.’01

165.3

-

-

23.7

% chng.

-

+27

-

-

+37

27

Mar.’02

92.29

4.15

30.68

1.23

-

-

26.74

1.51

% chng.

-

+30

+.8

-

-

+15

+26

28

Mar.’02

19.3

1.2

-

-

-

-

-

-

6.61

.69

% chng.

-

-

-

-

-43

-56

-

-

-

+5

+35

29

Mar.’02

281.8

20.1

-

-

1037

68.5

% chng.

-

+6

+6

-

-

+4

30

Mar.’02

-

-

-

-

-

-

-

-

123.3

21.6

% chng.

-

-

-

-

-

-

-

-

-

+4

+57

31

FDC

Mar.’02

139.3

24.55

-

-

50.93

10.25

201.3

37.38

% chng.

-

-

+24

+18

+21

+52

32

Glenmark

Mar.’02

-

-

-

66.7

5.5

-

-

-

-

-

% chng.

-

-

-

-

+31

+5

-

-

-

-

-

33

Mar.’01

-

-

-

-

-

-

-

-

-

-

% chng.

-

-

-

-

-

-

-

-

-

-

-

34

Duphar

Mar.’01

-

-

-

20.93

2.04

-

-

-

-

-

% chng.

-

-

-

-

+7

-21

-

-

-

-

-

35

Kopran

Mar.’01

166.2

9.58

-

56.75

4.79

-

-

-

54.30

4.27

% chng.

-

-

-

-

+1

+19

-

-

-

+6

+2

36

Siris

Mar.’01

-

-

-

-

-

-

-

-

-

-

% chng.

-

-

-

-

-

-

-

-

-

-

-

37

Krebs Bio

Mar.’01

41.44

13.01

-

-

-

-

-

-

8.81

3.12

% chng.

-

-

-

-

-

-

-

-

-

+24

+31

38

Jenburkt

Mar.’01

-

-

-

-

-

-

-

-

-

-

% chng.

-

-

-

-

-

-

-

-

-

-

-

39

Max India

Jun.’01

-

-

-

-

-

-

-

-

-

-

% chng.

-

-

-

-

-

-

-

-

-

-

-

40

Elder Pharma.

Apr.'02

187.4

7.47

50.15

2.27

-

-

57.08

3.54

% chng.

-

+6

+10

-

-

+11

+4

41

Hoechst Marion

Dec.'01

413

23.9

-

-

132.7

12.2

% chng.

-

-

-

+2

+58

42

Ajanta Pharma.

Mar.'01

-

-

-

20.9

1.5

-

-

-

23.2

4.2

% chng.

-

-

-

-

-41

-33

-

-

-

-

-

43

SmithKline

Dec.'00

-

-

-

75.2

7.3

319.5

30.5

-

-

-

% chng.

-

-

-

-

+1

+7

-2.1

+23

-

-

-

No.

Comp.

Acc. Year

Ressult

Quarter 1

Quarter 2

Quarter 3

Quarter 4

Result

(Cr.)

(Cr.)

(Cr.)

(Cr.)

(Cr.)

(Cr.)

(Cr.)

(Cr.)

(Cr.)

(Cr.)

(Cr.)

(Cr.)

44

E. Mer ck

Dec.‘02

338

44.7

45.5

-

-

% chng.

-

+8

+16

+8

-

-

-

-

-

45

Mar. 01

477.7

39.97

-

-

-

-

-

-

145.0

19.05

% chng.

-

-

-

-

-

-

-

-

-

+12

+32

46

Mar.’01

-

-

-

-

-

-

-

-

17.99

-1.13

% chng.

-

-

-

-

-

-

-

-

-

+22

-

47

Lederle

Mar.'01

-

-

-

47.1

3.2

-

-

-

% chng.

-

-

-

-8

-47

-

-

-

48

IDL

Mar.'01

-

-

-

33.7

3.8

-

-

-

-

-

% chng.

-

-

-

-

+23

+58

-

-

-

-

-

49

Mar.02

-

-

-

152

55.3

-

-

-

-

-

588.8

62.7

% chng.

-

-

-

-

+30

+9

-

-

-

15.7

+2.5

50

American Reme.

Mar.'01

94.29

-11.7

-

20.6

24.49

-

-

-

-

-

% chng.

-

-

-

-

-13

-

-

-

-

-

-